Skip to main content

Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts

Publication ,  Conference
Feng, Y; Jannetti, S; Meshaw, R; Vaidyanathan, G; Zalutsky, M
Published in: JOURNAL OF NUCLEAR MEDICINE
2021

Duke Scholars

Published In

JOURNAL OF NUCLEAR MEDICINE

EISSN

1535-5667

ISSN

0161-5505

Publication Date

2021

Volume

62

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Feng, Y., Jannetti, S., Meshaw, R., Vaidyanathan, G., & Zalutsky, M. (2021). Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts. In JOURNAL OF NUCLEAR MEDICINE (Vol. 62).
Feng, Yutian, Stephen Jannetti, Rebecca Meshaw, Ganesan Vaidyanathan, and Michael Zalutsky. “Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts.” In JOURNAL OF NUCLEAR MEDICINE, Vol. 62, 2021.
Feng Y, Jannetti S, Meshaw R, Vaidyanathan G, Zalutsky M. Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts. In: JOURNAL OF NUCLEAR MEDICINE. 2021.
Feng Y, Jannetti S, Meshaw R, Vaidyanathan G, Zalutsky M. Therapeutic efficacy of single-dose iso-[211At]SAGMB-anti-HER2 sdAb in mice with subcutaneous HER2-expressing breast carcinoma xenografts. JOURNAL OF NUCLEAR MEDICINE. 2021.

Published In

JOURNAL OF NUCLEAR MEDICINE

EISSN

1535-5667

ISSN

0161-5505

Publication Date

2021

Volume

62

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3202 Clinical sciences
  • 1103 Clinical Sciences